<DOC>
	<DOCNO>NCT02736825</DOCNO>
	<brief_summary>Up 260 subject present skin laxity face neck randomize one two treatment group . Subjects meet entrance criterion receive study treatment , complete two post treatment phone contact follow-up study visit 90 , 180 365 day post treatment . Study image obtain pre-treatment , immediately post-treatment , follow-up visit qualitative quantitative assessment efficacy .</brief_summary>
	<brief_title>Simulines Non-Inferiority Pivotal Study</brief_title>
	<detailed_description>This prospective , randomize , double blind , multi-center , parallel arm , non-inferiority , pivotal clinical trial demonstrate safety efficacy new transducer delivers two simultaneous line treatment treatment depth inferior standard transducer improve jawline definition submental skin laxity . Changes baseline quantitative measure neck submental lift assess study follow-up visit . Global Aesthetic Improvement Scale score , Merz Jawline Grading Scale score , 3D volumetric change baseline post treatment , patient satisfaction patient-reported improvement obtain .</detailed_description>
	<mesh_term>Cutis Laxa</mesh_term>
	<criteria>Male female , age 30 70 year . Subject good health . Body Mass Index ( BMI ) â‰¤30 . Skin laxity area ( ) treat determine trained physician assessor . Willingness avoid excessive prolonged exposure sunlight , tan booth , sun lamp , ultraviolet ( UV ) light source . Willingness apply study provide sunscreen ( Neocutis MicroDay Rejuvenating Cream ) daily study exit help limit sun exposure . Willingness avoid periodically stop use Sunless Tanners ( washout period two week prior study visit require ) . Understands accepts obligation undergo procedure area treat followup period Willingness avoid nonemergent dental procedure 3 week prior to/ post treatment . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study . Subjects childbearing potential must negative urine pregnancy test result must lactate Screening Visit willing able use acceptable method birth control ( e.g . barrier method use spermicidal agent , hormonal method , intrauterine device ( IUD ) , surgical sterilization , abstinence ) study . Women consider childbearing potential one follow condition document medical history : a. Postmenopausal least 12 month prior study ; b . Without uterus and/or ovary ; c. Bilateral tubal ligation least six month prior study enrollment . Absence physical psychological condition unacceptable investigator . Willingness refrain use aspirin , Ibuprofen , Naproxen nonsteroidal antiinflammatory drug ( NSAID ) prior study treatment chronic use entire posttreatment study period . Washout period , chronic user , 4 week prior study treatment . After study treatment complete , limited acute NSAID use , i.e. , maximum 23 dos 2 week period , allow need . Willingness ability provide write consent studyrequired photography adherence photography procedure ( i.e. , removal jewelry makeup ) . Willingness ability provide write informed consent HIPAA authorization prior performance studyrelated procedure . Presence active systemic local skin disease may affect wound healing . History Bell 's Palsy . History chronic frequently recur episodic ( recurrent episode past 12 month ) autoimmune diseases Multiple Sclerosis , Crohn 's Disease , Psoriasis , Myasthenia Gravis , LambertEaton Syndrome require immune suppressant therapy ( biologic drug corticosteroid treatment ) . Palpable thyroid lesion , lymphadenopathy , pathological change within treatment area . History skin cancer area treat , basal cell nevus syndrome , jaw cyst . Known allergy sensitivity Ibuprofen . Severe solar elastosis . BMI &gt; 30 . Significant change weight ( e.g . 5 pound ) past 6 month anticipate significant change weight diet course study . Pregnant within past year . Excessive subcutaneous fat area ( ) treat . Excessive skin laxity area ( ) treat determine trained physician assessor . Significant scarring area ( ) treat would interfere assess result . Open wound lesion area ( ) treat . Severe cystic acne area ( ) treat . Active implant ( e.g. , pacemaker defibrillator ) , metallic implant treatment area ( dental implant include ) . Inability understand protocol give inform consent . Microdermabrasion , prescription level glycolic acid treatment treatment area ( ) within two week prior study participation study . Marked asymmetry , ptosis , excessive dermatochalasis , deep dermal scarring , thick sebaceous skin area ( ) treat . History chronic drug alcohol abuse . Concurrent therapy , investigator 's opinion , would interfere evaluation safety efficacy study device . Subjects anticipate need surgery overnight hospitalization study . Subjects , investigator 's opinion , history poor cooperation , noncompliance medical treatment , unreliability . Concurrent enrollment study involve use investigational device drug . Current smoker history smoking last five year . Current user nicotinecontaining product , e.g. , ecigarettes , Nicorette gum , nicotine patch , etc . History follow cosmetic treatment area ( ) treat : 1 . Any energy base device ( radiofrequency ( RF ) , microfocused ultrasound ( MFU ) , etc . ) procedure skin tighten within past year ; 2 . Injectable filler type within past : . 12 month Hyaluronic acid filler ( e.g . Restylane ) ii . 12 month Ca Hydroxylapatite filler ( e.g . Radiesse ) iii . 24 month Long Lasting Hyaluronic acid ( e.g . Voluma ) PolyLLactic acid filler ( e.g . Sculptra ) iv . Ever permanent filler ( e.g . Silicone , ArteFill ) c. Neurotoxins within past six month ( neuromodulators allow glabella forehead , allow temple , crow 's fee anywhere lateral canthus ) ; d. Fractional fully ablative resurface laser treatment within past two year ; e. Nonablative , rejuvenative laser light treatment within past six month ; f. Surgical dermabrasion deep facial peel within past two year ; g. Facelifts , neck surgery ( e.g . thyroid , neck lift , neck liposuction , etc . ) within past two year ; h. Micro needle within past year ; i. Kybella , Coolsculpting , Mesotherapy within past two year ; j . Any history contour thread . History ( prior year ) current use follow prescription medication : 1 . Accutane systemic retinoids within past six month ; 2 . Initiation topical retinoids within past 6 month throughout course study ; 3 . Antiplatelet agents/Anticoagulants ( Coumadin , Heparin , Plavix ) ; 4 . Systemic steroid include prednisone ; 5 . Dermal regulator collagen ; 6 . Initiation bioidentical hormone human growth hormone ( HGH ) within past 6 month throughout course study ; 7 . Psychiatric drug investigator opinion would impair subject understand protocol requirement understand signing informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>